Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Other Non-Current Liabilities: 2019-2025

Historic Other Non-Current Liabilities for Sotera Health (SHC) over the last 5 years, with Sep 2025 value amounting to $52.4 million.

  • Sotera Health's Other Non-Current Liabilities rose 6.74% to $52.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.4 million, marking a year-over-year increase of 6.74%. This contributed to the annual value of $49.3 million for FY2024, which is 2.87% up from last year.
  • Per Sotera Health's latest filing, its Other Non-Current Liabilities stood at $52.4 million for Q3 2025, which was up 0.50% from $52.1 million recorded in Q2 2025.
  • Over the past 5 years, Sotera Health's Other Non-Current Liabilities peaked at $52.4 million during Q3 2025, and registered a low of $42.5 million during Q4 2021.
  • Moreover, its 3-year median value for Other Non-Current Liabilities was $48.1 million (2024), whereas its average is $48.1 million.
  • Per our database at Business Quant, Sotera Health's Other Non-Current Liabilities dropped by 8.02% in 2022 and then rose by 10.78% in 2024.
  • Quarterly analysis of 5 years shows Sotera Health's Other Non-Current Liabilities stood at $42.5 million in 2021, then rose by 7.14% to $45.5 million in 2022, then climbed by 5.41% to $47.9 million in 2023, then grew by 2.87% to $49.3 million in 2024, then increased by 6.74% to $52.4 million in 2025.
  • Its last three reported values are $52.4 million in Q3 2025, $52.1 million for Q2 2025, and $50.2 million during Q1 2025.